Lai San Tham

6PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsPharmaceutical delivery technologiesGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 21, 2026
A Review of Semi-Mechanistic HbA1c Models in People with Type 2 Diabetes: Strengths, Limitations, and Applications.

|Jan 21, 2026
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.

Shobha Bhattachar, Lai San Tham, Beth Tidemann-Miller

|Aug 22, 2025
A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules.

Maria M Posada, Karen B Schneck, Bridget L Morse

|Aug 20, 2025
Mazdutide reduces body weight in adults with overweight or obesity: A high-dose Phase 1 trial.

Shobha N Bhattachar, Lai San Tham, Yan Li

|Jun 17, 2025
Evaluation of Four Semi-Mechanistic Models for Predicting Glycemic Control With a Glucagon Receptor Antagonist in People With Type 2 Diabetes.

Austin Yue Feng Tan, Karen Schneck, Parag Garhyan

|Oct 26, 2021
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide.

Lai San Tham, Kevin M Pantalone, Kathleen Dungan

Pageof 1

Frequent Collaborators

2 joint publications

Austin Yue Feng Tan

2 joint publications

Karen Schneck

2 joint publications

Parag Garhyan

2 joint publications

Kieren J Mather